Ashten Howard, PA
Physician Assistant · Carson City
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 6
Offices
6 locations · James J Lynch M D Ltd · 81 clinicians in this group
Hospitals listed: Carson Tahoe Regional Medical Center · Carson Valley Health. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Ashten Howard’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A54304 · Current
Licensed to practise in California · since 1995 · expires 2027-05-31 · Institute of Medicine (I) Rangoon.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Carson Tahoe Regional Medical CenterCarson City, NVAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Carson Tahoe Health, which runs 3 hospitalsPatients rate it 4 of 5 · 74% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — Postoperative hemorrhage or hematoma rate: 4.16 (2.72 to 5.6) · 1,398 cases, Jul 2022 – Jun 2024Worse than the national rate — SSI - Colon Surgery: 2.351, Oct 2024 – Sep 2025Worse than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 1.3 (1 to 1.5) · 851 cases, Jan 2024 – Dec 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.581, Oct 2024 – Sep 2025
- Carson Valley HealthGardnerville, NVCritical Access Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Barton Health, which runs 2 hospitals in 2 statesPatients rate it 5 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsNo measure marked better or worse than the national rate
See every measure and the patient survey for Carson Tahoe Regional Medical Center
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 8 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Postoperative hemorrhage or hematoma rateComplications and deaths | 4.16 (2.72 to 5.6) · 1,398 cases | Worse | Jul 2022 – Jun 2024 |
| SSI - Colon SurgeryInfections | 2.351 | Worse | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.3 (1 to 1.5) · 851 cases | Worse | Jan 2024 – Dec 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.581 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.78 (0 to 1.72) · 1,219 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.75 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 188.13 (138.51 to 237.75) · 100 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10 · 177 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.2 · 227 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.8 · 484 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.2 · 713 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 16.1 · 274 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4 · 3,013 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.14 (0 to 0.33) · 6,209 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.42) · 6,285 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.64 (1.59 to 5.68) · 1,496 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 3.15 (1.62 to 4.68) · 516 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.74 (5.1 to 18.37) · 474 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.61 (2.01 to 9.22) · 471 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.17 (0.73 to 3.61) · 313 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.36 (0 to 1.05) · 5,079 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.008 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.711 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.485 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.7 · 283 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.4 · 618 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -0.7 · 254 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -30.5 · 537 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -3.5 · 715 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (4 to 7.7) · 308 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11 (8.6 to 14.1) · 308 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.8 · 246 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.5 (10 to 18.3) · 217 cases | No different | Jan 2022 – Dec 2024 |
What patients said (1,001 patients answered, 34% of those asked)
| Cleanliness | 5 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 79% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 51% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Carson Valley Health
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Readmissions: 0 better, 7 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate for COPD patientsComplications and deaths | 9.5 · 48 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.4 · 71 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.3 · 95 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 13.3 · 32 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 5.1 · 485 cases | None | Jul 2024 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.7 · 79 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 1.5 · 78 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -5.8 · 98 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.7 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.7 to 8.6) · 52 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.8 (6.8 to 13.8) · 52 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19 · 54 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.5) · 262 cases | No different | Jan 2024 – Dec 2024 |
What patients said (293 patients answered, 30% of those asked)
| Cleanliness | 5 |
| Nurse communication | 5 |
| Doctor communication | 4 |
| Communication about medicines | 5 |
| Discharge information | 5 |
| Overall hospital rating | 5 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 86% |
| Nurses "always" communicated well | 85% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 72% |
| Yes, staff "did" give patients this information | 91% |
| Yes, staff "did" give patients information about help after discharge | 91% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 88% |
| Patients who gave a rating of "9" or "10" (high) | 82% |
| Staff "always" explained new medications | 84% |
| Nurses "always" explained things so they could understand | 81% |
| Nurses "always" listened carefully | 82% |
| Nurses "always" treated them with courtesy and respect | 93% |
| "Always" quiet at night | 62% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 60% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
Original Medicare doctor bills
$70,408
Medicare paid this office $70,408 for 358 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 173 | $14,947 | $77 |
| Short return visit (20+ min) | 151 | $14,322 | $57 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 27 | $6,533 | $242 |
| New patient visit (45+ min) | 55 | $4,693 | $85 |
| Aspiration and/or injection of fluid from large joint | 30 | $2,533 | $47 |
See all 18 services
| Return visit (30+ min) | 173 | $14,947 | $77 |
| Short return visit (20+ min) | 151 | $14,322 | $57 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 27 | $6,533 | $242 |
| New patient visit (45+ min) | 55 | $4,693 | $85 |
| Aspiration and/or injection of fluid from large joint | 30 | $2,533 | $47 |
| Testing for presence of drug, by chemistry analyzers | 32 | $1,949 | $61 |
| X-ray of lower and sacral spine, minimum of 4 views | 60 | $1,682 | $28 |
| Replacement of knee joint, both sides of knee | 13 | $1,594 | $123 |
| Mri scan of lower spinal canal without contrast | 12 | $1,350 | $113 |
| Partial removal of spine bone with release of lower spinal cord and/or nerves, 1 segment | 12 | $900 | $75 |
| Short return visit | 15 | $823 | $34 |
| New patient visit (30+ min) | 12 | $669 | $56 |
| X-ray of upper spine, 4-5 views | 19 | $531 | $28 |
| Partial removal of spine bone with release of spinal cord and/or nerves, each additional segment | 12 | $423 | $21 |
| X-ray of knee, 4 or more views | 14 | $413 | $28 |
| X-ray of lower and sacral spine, 2-3 views | 13 | $344 | $25 |
| X-ray of shoulder, minimum of 2 views | 13 | $278 | $20 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 30 | $186 | None |
Procedures Medicare counted
| Knee replacement | 1-10 | None |
| Laminectomy or laminotomy (partial removal of spine bones) | 47 | More than 75% of doctors who do this |
| Spinal fusion | 50 | More than 55% of doctors who do this |
Who their Medicare patients are
358 Original Medicare patients in 2024. Average age 75 · Under 65 6% · 85 and older 12% · Women 60% · Also on Medicaid 7% · Health risk score 1.02. At or below the middle of the specialty; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 68% · Diabetes 23% · Depression 22% · Coronary heart disease 21% · COPD 17% · Chronic kidney disease 16% · Cancer 13% · Heart failure 11% · Atrial fibrillation 11% · Stroke 5% · Dementia 4%.
The office billed $817,219, Medicare allowed $92,965 and paid $70,408; for 1,848 services of 73 kinds; $6,226 of it was for drugs given in the office and $64,181 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 358 | 1,848 | 75 | 1.02 | $817,219 | $70,408 |
| 2023 | 320 | 1,482 | 75 | 1.04 | $854,342 | $64,570 |
| 2022 | 222 | 490 | 74 | 0.92 | $2,018,520 | $35,023 |
| 2021 | 214 | 456 | 75 | 0.91 | $498,088 | $33,090 |
| 2020 | 143 | 406 | 73 | 0.96 | $298,889 | $24,067 |
| 2019 | 169 | 389 | 73 | 0.90 | $226,401 | $22,570 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 17 services
| Short return visit (20+ min) | 157 | $16,614 | $59 |
| Return visit (30+ min) | 90 | $7,146 | $74 |
| New patient visit (45+ min) | 67 | $6,168 | $92 |
| Mri scan of lower spinal canal without contrast | 29 | $3,682 | $127 |
| Replacement of knee joint, both sides of knee | 23 | $3,169 | $138 |
| Replacement of thigh bone and hip joint with prosthesis | 15 | $2,102 | $140 |
| Partial removal of spine bone with release of lower spinal cord or nerves and/or removal of disc | 20 | $1,916 | $96 |
| X-ray of lower and sacral spine, minimum of 4 views | 59 | $1,742 | $30 |
| Aspiration and/or injection of fluid from large joint | 25 | $1,499 | $47 |
| Partial removal of spine bone with release of lower spinal cord and/or nerves, 1 segment | 15 | $1,343 | $90 |
| X-ray of wrist, minimum of 3 views | 11 | $1,058 | $27 |
| X-ray of hip, 2-3 views | 20 | $798 | $32 |
| Testing for presence of drug, by chemistry analyzers | 11 | $670 | $61 |
| X-ray of upper spine, 4-5 views | 18 | $610 | $34 |
| X-ray of lower and sacral spine, 2-3 views | 20 | $570 | $27 |
| Partial removal of spine bone with release of spinal cord and/or nerves, each additional segment | 12 | $529 | $23 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 21 | $114 | None |
2022: 10 services
| Short return visit (20+ min) | 69 | $4,516 | $61 |
| Replacement of knee joint, both sides of knee | 29 | $4,409 | $147 |
| New patient visit (45+ min) | 37 | $4,174 | $113 |
| Return visit (30+ min) | 38 | $3,308 | $87 |
| Replacement of thigh bone and hip joint with prosthesis | 13 | $1,905 | $147 |
| Partial removal of spine bone with release of lower spinal cord or nerves and/or removal of disc | 11 | $1,192 | $108 |
| X-ray of lower and sacral spine, minimum of 4 views | 29 | $898 | $31 |
| X-ray of upper spine, 4-5 views | 15 | $539 | $36 |
| X-ray of lower and sacral spine, 2-3 views | 18 | $462 | $26 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 11 | $30 | None |
2021: 10 services
| Replacement of knee joint, both sides of knee | 38 | $5,671 | $149 |
| Short return visit (20+ min) | 50 | $3,224 | $60 |
| Replacement of thigh bone and hip joint with prosthesis | 15 | $2,171 | $145 |
| Return visit (30+ min) | 23 | $1,974 | $86 |
| Partial removal of spine bone with release of lower spinal cord and/or nerves, 1 segment | 18 | $1,823 | $101 |
| Partial removal of spine bone with release of lower spinal cord or nerves and/or removal of disc | 15 | $1,637 | $109 |
| New patient visit (45+ min) | 12 | $1,296 | $108 |
| New patient visit (30+ min) | 11 | $867 | $79 |
| X-ray of lower and sacral spine, minimum of 4 views | 20 | $638 | $32 |
| Partial removal of spine bone with release of spinal cord and/or nerves, each additional segment | 12 | $475 | $25 |
2020: 4 services
| Replacement of knee joint, both sides of knee | 19 | $2,939 | $155 |
| Replacement of thigh bone and hip joint with prosthesis | 11 | $1,711 | $156 |
| Short return visit (20+ min) | 26 | $1,293 | $50 |
| Insertion of cage or mesh device to spine bone and disc space during spine fusion | 11 | $330 | $30 |
2019: 9 services
| Replacement of knee joint, both sides of knee | 29 | $4,344 | $150 |
| Short return visit (20+ min) | 52 | $2,829 | $51 |
| Return visit (30+ min) | 34 | $2,502 | $74 |
| Aspiration and/or injection of fluid from large joint | 23 | $1,050 | $40 |
| X-ray of lower and sacral spine, minimum of 4 views | 12 | $401 | $33 |
| X-ray of knee, 4 or more views | 14 | $351 | $25 |
| X-ray of foot, minimum of 3 views | 12 | $243 | $20 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 21 | $43 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 18 | $2 | None |
Medicaid work
$1,417 in 2024
Medicaid paid $1,417 for 52 billed services this clinician did in 2024, up to 17 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 35 | $997 |
| Return visit (30+ min) | 17 | $420 |
| 2024 | 52 | 2 | 17 | $1,417 |
| 2023 | 60 | 2 | 23 | $2,515 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 40 | $1,329 |
| New patient visit (45+ min) | 20 | $1,185 |
Drugs they prescribed that Part D paid
$9,589
Pharmacies billed $9,589 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 30% of their Part D prescriptions (263 of 891) in 2024. Above the middle of the specialty; the typical physician assistant clinician is at 1%. Long-acting opioids: 5% of their opioid prescriptions.
883 generic and fewer than 11 brand-name prescriptions · $9,589 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Hydrocodone-Acetaminophen | 100 | $1,766 | $18 |
| Celecoxib | 24 | $1,235 | $51 |
| Oxycodone-Acetaminophen | 29 | $884 | $30 |
| Lidocaine | 11 | $877 | $80 |
| Gabapentin | 107 | $722 | $7 |
See all 13 drugs
| Hydrocodone-Acetaminophen | 100 | $1,766 | $18 |
| Celecoxib | 24 | $1,235 | $51 |
| Oxycodone-Acetaminophen | 29 | $884 | $30 |
| Lidocaine | 11 | $877 | $80 |
| Gabapentin | 107 | $722 | $7 |
| Oxycodone | 24 | $670 | $28 |
| Methylprednisolone | 99 | $621 | $6 |
| Cyclobenzaprine | 114 | $564 | $5 |
| Methocarbamol | 40 | $443 | $11 |
| Meloxicam | 137 | $434 | $3 |
| Pregabalin | 22 | $209 | $10 |
| Tramadol | 95 | $206 | $2 |
| Tizanidine | 32 | $201 | $6 |
Year by year
| 2024 | 891 | 315 | 30% (263) | None | $9,589 |
| 2023 | 673 | 292 | 28% (188) | 2% | $7,213 |
| 2022 | 563 | 286 | 34% (191) | None | $6,742 |
| 2021 | 392 | 210 | 34% (132) | None | $3,516 |
| 2020 | 326 | 168 | 29% (94) | None | $3,811 |
| 2019 | 289 | 188 | 29% (85) | 8% | $4,015 |
| 2018 | 39 | 26 | 0% (0) | 54% | $3,690 |
| 2017 | 63 | 32 | None | 25% | $3,655 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 11 drugs
| Methylprednisolone | 78 | $825 | $11 |
| Celecoxib | 24 | $733 | $31 |
| Hydrocodone-Acetaminophen | 75 | $672 | $9 |
| Cyclobenzaprine | 97 | $527 | $5 |
| Gabapentin | 73 | $479 | $7 |
| Methocarbamol | 37 | $394 | $11 |
| Meloxicam | 106 | $364 | $3 |
| Oxycodone-Acetaminophen | 29 | $267 | $9 |
| Tramadol | 78 | $248 | $3 |
| Pregabalin | 11 | $109 | $10 |
| Ibuprofen | 11 | $97 | $9 |
2022: 9 drugs
| Gabapentin | 72 | $844 | $12 |
| Celecoxib | 18 | $663 | $37 |
| Hydrocodone-Acetaminophen | 78 | $661 | $8 |
| Oxycodone-Acetaminophen | 52 | $570 | $11 |
| Cyclobenzaprine | 77 | $562 | $7 |
| Methylprednisolone | 50 | $539 | $11 |
| Meloxicam | 78 | $240 | $3 |
| Tramadol | 54 | $204 | $4 |
| Methocarbamol | 23 | $153 | $7 |
2021: 9 drugs
| Hydrocodone-Acetaminophen | 70 | $628 | $9 |
| Cyclobenzaprine | 76 | $516 | $7 |
| Gabapentin | 38 | $413 | $11 |
| Methylprednisolone | 27 | $188 | $7 |
| Meloxicam | 51 | $150 | $3 |
| Oxycodone-Acetaminophen | 18 | $109 | $6 |
| Methocarbamol | 16 | $92 | $6 |
| Tramadol | 38 | $83 | $2 |
| Tizanidine | 15 | $81 | $5 |
2020: 8 drugs
| Diclofenac | 24 | $544 | $23 |
| Cyclobenzaprine | 88 | $423 | $5 |
| Hydrocodone-Acetaminophen | 42 | $330 | $8 |
| Gabapentin | 35 | $264 | $8 |
| Oxycodone-Acetaminophen | 19 | $183 | $10 |
| Methylprednisolone | 18 | $148 | $8 |
| Meloxicam | 33 | $90 | $3 |
| Tramadol | 27 | $66 | $2 |
2019: 8 drugs
| Diclofenac | 37 | $1,193 | $32 |
| Hydrocodone-Acetaminophen | 31 | $286 | $9 |
| Methylprednisolone | 25 | $265 | $11 |
| Cyclobenzaprine | 47 | $184 | $4 |
| Gabapentin | 20 | $152 | $8 |
| Tramadol | 32 | $133 | $4 |
| Meloxicam | 26 | $80 | $3 |
| Oxycodone | 12 | $79 | $7 |
2018: 1 drug
| Moviprep | 16 | $1,602 | $100 |
Money from drug and device companies
$47 in 2025
| 2025 | 2 | 2 | None | $47 |
| 2024 | 2 | 2 | None | $55 |
| 2023 | 3 | 15 | None | $1,491 |
| 2022 | 4 | 4 | None | $64 |
| 2021 | 2 | 2 | None | $40 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Globus Medical | Reline | $26 | 1 payment
|
| Si-Bone | None | $21 | 1 payment
|
See all 2 published payments
| Si-Bone | Meals · 2025-07-30 | None | $21 |
| Globus Medical | Meals · 2025-04-01 | Reline | $26 |
See earlier years (2024, 2023, 2022, 2021)
2024: $55
| Smith+Nephew | Real Intelligence | $39 | 1 payment
|
| Medtronic | Catalyft Pl Expandable Interbody System | $16 | 1 payment
|
2023: $1,491
| Medtronic | Mazor X System | $1,450 | 13 payments
|
| Sanofi-Aventis U.S. | Synvisc-One | $22 | 1 payment
|
| Cerapedics | I-Factor Peptide Enhanced Bone Graft | $19 | 1 payment
|
2022: $64
| Pacira Pharmaceuticals | Iovera | $17 | 1 payment
|
| Medtronic | Kyphon Express II Kyphopak Tray | $16 | 1 payment
|
| DePuy Synthes Sales | Monovisc | $16 | 1 payment
|
| Kowa Pharmaceuticals America | Seglentis | $15 | 1 payment
|
2021: $40
| DePuy Synthes Sales | Monovisc | $28 | 1 payment
|
| Stryker | Yukon Oct Spinal System | $12 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 91.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1083145809
- Licence
- CA 54304, NV 2074California A54304: Current · expires 2027-05-31
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant (363A00000X)
- Mailing address
- 973 Mica Dr Ste 201, Carson City, NV, 89705
- NPI first listed
- 2017-03-23
- NPI last updated
- 2026-08-18
- NPI record certified
- 2026-08-18
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1375 Blossom Hill Rd, San Jose, CA, 95118